AtriCure, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-43.00
-29.00
-46.00
50.00
-48.00
-34.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-18.00
-18.00
-18.00
-4.00
-6.00
-4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
11.00
4.00
-22.00
-13.00
-19.00
-15.00
Cash Flow from Investing Activities
30.00
21.00
44.00
23.00
-156.00
-2.00
Cash Flow from Financing Activities
-2.00
0.00
-7.00
-7.00
189.00
14.00
Net Cash Inflow / Outflow
38.00
26.00
14.00
1.00
13.00
-3.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of AtriCure, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-43.674
143.469000000272
-186.00
-130.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-18.358
-7.06700000001342
-11.00
-159.77%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
11.135
132.664000000252
-121.00
-91.61%
Cash Flow from Investing Activities
30.234
162.206000000308
-132.00
-81.36%
Cash Flow from Financing Activities
-2.534
-282.771000000537
280.00
99.10%
Net Cash Inflow / Outflow
38.411
10.9180000000207
28.00
251.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.424
-1.18100000000224
1.00
64.10%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 151.70% vs 119.98% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
11.13
4.42
151.70%






